Skip to main content

Find Clinical Trials

Home
Conditions
Stage 1 cT1b-T1cN0M0

Clinical trial condition

Stage 1 cT1b-T1cN0M0

Explore clinical trials studying Stage 1 cT1b-T1cN0M0. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Stage 1 cT1b-T1cN0M0 trial results

Recruiting

Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer

NCT06318897

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +6 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details